DNA

4DMT to Participate in 8th Annual Evercore Healthcare Conference

EMERYVILLE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage…

3 months ago

Konica Minolta Healthcare Reinforces Leadership in Advanced Radiography with Seven Scientific Presentations on Dynamic Digital Radiography at RSNA 2025

Dynamic Digital Radiography pulmonary Konica Minolta's IWS workstation processes and quantifies Dynamic Digital Radiography diaphragmatic motion data. WAYNE, N.J., Nov.…

3 months ago

Sagimet Biosciences to Participate in the 8th Annual Evercore ISI Healthcare Conference

SAN MATEO, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel…

3 months ago

10k Science, an NIH-funded platform for science education, launches a new VR experience on UC Davis research into non-opioid pain relief

OAKLAND, Calif., Nov. 19, 2025 /PRNewswire/ -- Today, educational software company Dynamoid announced the launch of the 10k Science immersive 3D…

3 months ago

Helping Families Navigate I/DD Services funded by Medicaid- 10,000 Users and Counting

PALATINE, Ill., Nov. 19, 2025 /PRNewswire/ -- The IDD Navigator platform, launched by Little City with funding from The Coleman Foundation,…

3 months ago

DeepView™ System Featured at 2025 US Burn Conferences

DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence…

3 months ago

EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration

– No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show…

3 months ago

Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells

NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology…

3 months ago

Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease

Renowned urologist Dr. Mark Hong sets new global benchmark for urologist-led, MRI-guided prostate treatment, leading a growing movement toward incision-free…

3 months ago